2Clinical and Laboratory Standards Institute. Performance standards for antimierobial susceptibility testing, twenty-first informational supplement[S]. M100-$21. CLSI, 2011.
3Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, twentieth informational supplement[S], M100-S20. CLSI, 2010.
4Musta A C, Riederer K, Shemes S, et al. Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years[J]. Clin Microbiol, 2009, 47(6):1640-1644.
5Nordmann P, Cuzon G, Naas T, The real threat of Klehsiella pneumoniae earbapenemase-producing bacteria[J]. Lancet In ect Dis, 2009, 9(4): 228-236.
6Wu Q, Liu Q, Han L, et al. Plasmid-mediated carbapenem- hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring hlgh-level aminoglyeoside resistance in carbapenem- resistant Enterobaeter cloacae in China[J]. Diagn Mierobiol Infect Dis, 2010, 66(3): 326-328.
7Cai J C, Zhou H W, Zhang R, et al. Emergence of Serratia marcescens , Klebsiella pneumoniae , and Escherichia coli iso- lates possessing the plasmid-mediated carbapenem hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hos- pital[J]. Antimicrob Agents Chemother, 2008, 52: 2014- 2018.
